Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,084 public trials 6,466 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

NCT06172296

Conditions
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neoplasms, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 179 locations
View Trial Details
Recruiting

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

NCT07188896

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma (aRCC), Carcinoma, +16 more
Locations
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

NCT05849662

Conditions
Bone Marrow Diseases, CBL Syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital of Colorado Denver, Colorado, United States
View all 21 locations
View Trial Details
Recruiting

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

NCT06846606

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

NCT06644755

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liposarcoma, +17 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • UZ Leuven Europe Leuven Leuven, Belgium
View Trial Details

Related conditions